Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
3(25%)
Results Posted
20%(1 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
10
83%
Ph phase_4
1
8%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(5)
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Not yet recruiting2
Recruiting2
Active, not recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (9.1%)
N/A10 (90.9%)

Trials by Status

completed542%
not_yet_recruiting217%
recruiting217%
active_not_recruiting18%
terminated18%
unknown18%

Recent Activity

Clinical Trials (12)

Showing 12 of 12 trials

All 12 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
12